전체 프로그램

ADC 890 · Antibody 4071 · CGT 2714 · 다음 갱신 D-5 · 마지막 9월 2일

PopularRecently updatedCuratedMost trialsNeeds refreshORRLatestPhase 3FDA approved2,047 programs
AntibodyCurated CorestaleMario Negri Institute for Pharm…Approved

Certolizumab pegol (Certolizumab pegol)

Rheumatoid Arthritis · Crohn's Disease

#CrohnsDisease#Antibody#Approved#BioJungboMoa-pick#Popular+3
Trials 60Status Active
CGTLimited DatastaleTransMolecularPhase 1

Chlorotoxin (EQ, Chlorotoxin, Chlorotoxin (EQ)-CD28-CD3zeta-CD19t-expressing CAR T-lymphocytes (via ICT delivery))

Recurrent Glioblastoma; Recurrent Malignant Glioma · CD19

#CD19#CGT#Phase1#Popular#cell-gene-therapy+5
Trials 60Status Recruiting
CGTLimited DatastaleTransMolecularPhase 1

Chlorotoxin (EQ, Chlorotoxin, Chlorotoxin (EQ)-CD28-CD3zeta-CD19t-expressing CAR T-lymphocytes (via ICT/ICV dual delivery))

Recurrent Glioblastoma; Recurrent Malignant Glioma · CD19

#CD19#CGT#Phase1#Popular#cell-gene-therapy+5
Trials 60Status Recruiting
AntibodyCurated CorestaleGlaxoSmithKlinePhase 2

Dostarlimab (Dostarlimab)

Neoplasms · Stomach Neoplasm

#StomachNeoplasm#Antibody#Phase2#BioJungboMoa-pick#Popular+3
Trials 60Status Discontinued
CGTLimited DatastaleTurnstone Biologics, Corp.Phase 1

RT-01 (Oncolytic Virus Injection, Oncolytic Virus Injection(RT-01))

Advanced Solid Tumor · Advanced Solid Tumor

#AdvancedSolidTumor#CGT#Phase1#Popular#cell-gene-therapy+4
Trials 60Status Active
AntibodyLimited DatastaleRochePhase 2

trastuzumab (Herceptin, Pertuzumab + trastuzumab)

Elderly Metastatic Breast Cancer Population · Elderly Metastatic Breast Cancer Populat

#ElderlyMetastaticBreastCancerPop#Antibody#Phase2#Popular#monoclonal-antibody+1
Trials 60Status Active
AntibodyLimited DatastaleSun Yat-sen UniversityPhase 3

Serplulimab (Serplulimab)

Colorectal Cancer; Liver Metastases · Solid Tumor Cancer

#SolidTumorCancer#Antibody#Phase3#Popular#monoclonal-antibody+3
Trials 60Status Recruiting
ADCLimited DatastaleCelldex TherapeuticsPhase 2

nivolumab OR pembrolizumab (glembatumumab vedotin and PD-1 targeted checkpoint inhibitor, glembatumumab vedotin and PD-1 targeted checkpoint inhibitor (nivolumab OR pembrolizumab))

Melanoma · PD-1

#PD-1#ADC#Phase2#Popular#antibody-drug-conjugate+3
Trials 60Status Discontinued
AntibodyLimited DatastaleBristol Myers SquibbPhase 2

nivolumab (Opdivo, ipilimumab + nivolumab)

Solid Tumor; Non Small Cell Lung Cancer · Solid Tumor

#SolidTumor#Antibody#Phase2#Popular#monoclonal-antibody+2
Trials 60Status Recruiting
CGTStandard DatabasestaleAbClonPhase 2

Anti-CD19 Chimeric Antigen Receptor T cell (AT101, AT101(Anti-CD19 Chimeric Antigen Receptor T cell))

B-cell Non Hodgkin Lymphoma · CD19

#CD19#CGT#Phase2#Popular#cell-gene-therapy+5
Trials 59Status Recruiting
AntibodyLimited DatastaleRegeneronPhase 2

Cemiplimab + Fianlimab [Fixed Dose Combination (FDC, Cemiplimab + Fianlimab [Fixed Dose Combination, Cemiplimab + Fianlimab [Fixed Dose Combination (FDC)])

Ovarian Cancer; Fallopian Tube Cancer · Ovarian Cancer

#OvarianCancer#Antibody#Phase2#Popular#monoclonal-antibody+3
Trials 59Status Recruiting
AntibodyLimited DatastaleUCB PharmaApproved

Certolizumab (Certolizumab)

Psoriasis; Atopic Dermatitis · Chronic Nonbacterial Osteomyelitis

#ChronicNonbacterialOsteomyelitis#Antibody#Approved#Popular#monoclonal-antibody+3
Trials 59Status Recruiting
AntibodyLimited DatastaleBristol Myers SquibbPhase 2

nivolumab (Opdivo, Ipilimumab and nivolumab)

Mesothelioma; Pancreatic Cancer · Uveal Melanoma, Metastatic

#UvealMelanomaMetastatic#Antibody#Phase2#Popular#monoclonal-antibody+3
Trials 59Status Recruiting
CGTStandard DatabasestaleImmunityBio, Inc.Phase 2

Activated NK Cells (M-CENK, M-CENK (Activated NK Cells))

High-risk Prostate Cancer · High-risk Prostate Cancer

#High-riskProstateCancer#CGT#Phase2#Popular#cell-gene-therapy+3
Trials 59Status Discontinued
CGTLimited DatastaleBinhui Biopharmaceutical Co., L…Phase 1

IDOV-SAFETM (Oncolytic Virus injection, Oncolytic Virus injection(IDOV-SAFETM))

Neoplasms · Neoplasms

#Neoplasms#CGT#Phase1#Popular#cell-gene-therapy+4
Trials 59Status Recruiting
ADCStandard DatabasestaleRocheDM1 via butelase-1 with ABD…Phase 3

T-DM1 (Trastuzumab emtansine, Trastuzumab emtansine (T-DM1))

Unrespectable Locally Advanced and or Metastatic HER2 Positive Breast Cancer Participants · HER2

#HER2#ADC#Phase3#Popular#antibody-drug-conjugate+4
Trials 59Status Recruiting
CGTStandard DatabasestaleSMT bio Co., Ltd.Phase 2

allogeneic Natural Killer cell ('SMT-NK' Inj, 'SMT-NK' Inj (allogeneic Natural Killer cell))

Biliary Tract Cancer · Biliary Tract Cancer

#BiliaryTractCancer#CGT#Phase2#Popular#cell-gene-therapy+4
Trials 58Status Active
CGTAAVLimited DatastaleBayerPhase 1

AAVrh.10hFXN, serotype rh.10 adeno-associated virus (AAV, AAVrh.10hFXN, serotype rh.10 adeno-associated virus, AAVrh.10hFXN, serotype rh.10 adeno-associated virus (AAV) gene transfer vector expressing the cDNA coding for human FXN)

Friedreich Ataxia; Cardiomyopathies · Friedreich Ataxia

#FriedreichAtaxia#CGT#Phase1#Popular#cell-gene-therapy+5
Trials 58Status Recruiting
CGTLimited DatastaleCoronado Biosciences, Inc.Phase 2

Allogeneic natural killer cells (Allogeneic natural killer cells)

Leukemia; Lymphoma · Fallopian Tube Cancer

#FallopianTubeCancer#CGT#Phase2#Popular#cell-gene-therapy+5
Trials 58Status Discontinued
ADCStandard DatabasestaleFavrillederuxtecan for metastatic b…Phase 2

Antibody-Drug Conjugate Therapy (Antibody-Drug Conjugate Therapy)

Metastatic Bladder Urothelial Carcinoma; Metastatic Renal Pelvis and Ureter Urothelial Carcinoma · FRα

#FR#ADC#Phase2#Popular#antibody-drug-conjugate+5
Trials 58Status Recruiting

8 / 103 pages

← PreviousNext →